[18f]ml-10 PET Imaging Fails to Assess Early Response to Neoadjuvant Chemotherapy in a Preclinical Model of Triple Negative Breast Cancer

EJNMMI Research - Germany
doi 10.1186/s13550-019-0587-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Identification of Biomarkers Including 18fdg-Pet/Ct for Early Prediction of Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2015English

A Comparison of Near-Infrared Diffuse Optical Imaging and 18f-FDG PET/CT for the Early Prediction of Breast Cancer Response to Neoadjuvant Chemotherapy

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2016English

Neutrophil–lymphocyte Ratio Predicts Response to Chemotherapy in Triple-Negative Breast Cancer

Current Oncology
Oncology
2018English

Now Is the Time to Use FDG-PET/CT to Optimize Neoadjuvant Treatment in Triple Negative Breast Cancer!

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2018English

Targeted-Gene Sequencing to Catch Triple Negative Breast Cancer Heterogeneity Before and After Neoadjuvant Chemotherapy

Cancers
Cancer ResearchOncology
2019English

Comparative Analysis of Different Neoadjuvant Chemotherapy Regimens for Triple-Negative Breast Cancer

Tumors of female reproductive system
2017English

The Use of Molecular Breast Imaging to Assess Response in Women Undergoing Neoadjuvant Therapy for Breast Cancer

Clinical Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2012English

Prediction of Response to Neoadjuvant Chemotherapy and Radiation Therapy With Baseline and Restaging 18f-FDG PET Imaging Biomarkers in Patients With Esophageal Cancer

Radiology
Nuclear MedicineRadiologyImaging
2018English

Role of Magnetic Resonance Imaging in the Evaluation of Breast Cancer Response to Neoadjuvant Chemotherapy

In Vivo
BiochemistryMedicineGeneticsPharmacologyMolecular Biology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy